INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaJérôme Fayette, Helena Rebelo‐de‐Andrade, Makoto Tahara et al.|Clinical Cancer Research|2025Cited by 26
Pre-operative cellular dissociation grading in biopsies is highly predictive of post-operative tumour stage and patient outcome in head and neck squamous cell carcinomaMoritz Jesinghaus, Melanie Boxberg, Katja Steiger et al.|British Journal of Cancer|2020Cited by 19
Molecular subtyping of head and neck cancer – Clinical applicability and correlations with morphological characteristicsFabian Stögbauer, Konrad Klinghammer, Korinna Jöhrens et al.|Oral Oncology|2024Cited by 6